Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Progyny, Inc.PGNY · Entity 4521 | Director · Executive Chairman | January 02, 2026 | January 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Progyny, Inc.
Report date January 02, 2026 · Filed January 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 238,462 |
Reported balance
After 2026-01-02 transaction · row 1
1 source rowRow 1 · 2026-01-02 · Tax withholding · Disposed 2,171 · Balance 238,462 F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2022 Filed Mar 2, 2022 22:43 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-001937 · edgar.xml · derivative · entry 10 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,983,680 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:43 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 16,952 | $43.16 | $731,648.32 |
DisclosureSEC source: 0001179110-22-001937 · edgar.xml · nonDerivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.01 to $43.59, inclusive. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:43 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 25,748 | $42.45 | $1,093,002.60 |
DisclosureSEC source: 0001179110-22-001937 · edgar.xml · nonDerivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,952 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.99, inclusive. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:43 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,600 | $41.77 | $192,142.00 |
DisclosureSEC source: 0001179110-22-001937 · edgar.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 126,700 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.11 to $41.99, inclusive. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:43 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,100 | $40.64 | $44,704.00 |
DisclosureSEC source: 0001179110-22-001937 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,300 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.01 to $40.99, inclusive. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:43 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,600 | $39.32 | $62,912.00 |
DisclosureSEC source: 0001179110-22-001937 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,400 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.96 to $39.99, inclusive. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:43 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-22-001937 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:43 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 139,776 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-001937 · edgar.xml · derivative · entry 9 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,033,680 Underlying: Common Stock · 139,776 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:43 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 139,776 | $39.13 | $5,469,434.88 |
DisclosureSEC source: 0001179110-22-001937 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on December 10, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.99 to $39.55, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:43 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 139,776 | $0.91 | $127,196.16 |
DisclosureSEC source: 0001179110-22-001937 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,600 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-001358 · edgar.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,173,456 Underlying: Common Stock · 1,600 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,600 | $41.00 | $65,600.00 |
DisclosureSEC source: 0001179110-22-001358 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.00 to $41.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| February 16, 2022 Filed Feb 17, 2022 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,600 | $0.91 | $1,456.00 |
DisclosureSEC source: 0001179110-22-001358 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,600 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,624 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-001358 · edgar.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,175,056 Underlying: Common Stock · 7,624 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 7,624 | $41.36 | $315,328.64 |
DisclosureSEC source: 0001179110-22-001358 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.33 to $41.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| February 15, 2022 Filed Feb 17, 2022 21:36 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 7,624 | $0.91 | $6,937.84 |
DisclosureSEC source: 0001179110-22-001358 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 02:09 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-001300 · edgar.xml · derivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,182,680 Underlying: Common Stock · 1,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 02:09 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,000 | $42.00 | $42,000.00 |
DisclosureSEC source: 0001179110-22-001300 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.0050, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. Read SEC document |
| February 11, 2022 Filed Feb 16, 2022 02:09 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 1,000 | $0.91 | $910.00 |
DisclosureSEC source: 0001179110-22-001300 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 23:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 704 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,183,680 Underlying: Common Stock · 704 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 23:39 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 704 | $51.27 | $36,094.08 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.08 to $51.76, inclusive. Read SEC document |
| January 04, 2022 Filed Jan 5, 2022 23:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 704 | $0.91 | $640.64 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,704 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,184,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:39 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 50,000 | $51.17 | $2,558,500.00 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.93 to $51, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4). Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 23:39 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-22-000282 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantEmployee Stock Option (Right to Buy) · Derivative | 333,000 | $0.00 Strike: $50.35 | $0.00 |
DisclosureSEC source: 0001179110-22-000014 · edgar.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 333,000 Underlying: Common Stock · 333,000 shares Expires 2031-12-31 F6 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option will vest January 1, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through January 1, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | GrantCommon Stock | 84,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-22-000014 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,000 F4 · shares: Represents the number of shares of Issuer common stock underlying restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Issuer common stock. One-fourth (1/4th) of the RSUs will vest on January 1, 2023 and the remainder of the shares will vest in equal quarterly installments thereafter through January 1, 2026, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 73,095 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-22-000014 · edgar.xml · derivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,234,384 Underlying: Common Stock · 73,095 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 73,095 | $52.18 | $3,814,097.10 |
DisclosureSEC source: 0001179110-22-000014 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.11 to $52.39, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2). Read SEC document |
| December 29, 2021 Filed Jan 3, 2022 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 73,095 | $0.91 | $66,516.45 |
DisclosureSEC source: 0001179110-22-000014 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 66,005 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · derivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,307,479 Underlying: Common Stock · 66,005 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 66,005 | $52.40 | $3,458,662.00 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.39 to $52.61, inclusive. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 66,005 | $0.81 | $53,464.05 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,005 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,900 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · derivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,373,484 Underlying: Common Stock · 10,900 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 10,900 | $52.80 | $575,520.00 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $52.68 to $53.15, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (4). Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:45 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 10,900 | $0.91 | $9,919.00 |
DisclosureSEC source: 0001179110-21-011263 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:57 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009908 · edgar.xml · derivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,384,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:57 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 4,100 | $63.12 | $258,781.34 |
DisclosureSEC source: 0001179110-21-009908 · edgar.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.31, inclusive. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:57 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 10,467 | $62.40 | $653,147.08 |
DisclosureSEC source: 0001179110-21-009908 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,100 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.99, inclusive. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:57 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 9,223 | $61.49 | $567,137.95 |
DisclosureSEC source: 0001179110-21-009908 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,567 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.005 to $61.995, inclusive. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:57 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 25,160 | $60.63 | $1,525,372.80 |
DisclosureSEC source: 0001179110-21-009908 · edgar.xml · nonDerivative · entry 3 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,790 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.96, inclusive. Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:57 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 1,050 | $59.81 | $62,796.51 |
DisclosureSEC source: 0001179110-21-009908 · edgar.xml · nonDerivative · entry 2 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,950 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.54 to $59.99, inclusive. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6) and (7). Read SEC document |
| November 03, 2021 Filed Nov 5, 2021 20:57 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-009908 · edgar.xml · nonDerivative · entry 1 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 22:55 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009865 · edgar.xml · derivative · entry 10 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,434,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 22:55 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 300 | $63.04 | $18,912.51 |
DisclosureSEC source: 0001179110-21-009865 · edgar.xml · nonDerivative · entry 8 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8).The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.015 to $63.09, inclusive. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 22:55 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 11,041 | $62.24 | $687,157.61 |
DisclosureSEC source: 0001179110-21-009865 · edgar.xml · nonDerivative · entry 7 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8).The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.99, inclusive. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 22:55 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 38,659 | $61.79 | $2,388,608.17 |
DisclosureSEC source: 0001179110-21-009865 · edgar.xml · nonDerivative · entry 6 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,341 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8).The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.54 to $61.99, inclusive. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 22:55 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionCommon Stock | 50,000 | $0.91 | $45,500.00 |
DisclosureSEC source: 0001179110-21-009865 · edgar.xml · nonDerivative · entry 5 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 22:55 UTC | Progyny, Inc. PGNY · Entity 4521 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001179110-21-009865 · edgar.xml · derivative · entry 9 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,484,384 Underlying: Common Stock · 50,000 shares Expires 2027-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option vested on January 16, 2018, and the one thirty-sixth (1/36th) of the remaining shares subject to the option vested or shall vest on each month thereafter, subject to the Reporting Person continuing to provide service through such date. Read SEC document |
| November 01, 2021 Filed Nov 3, 2021 22:55 UTC | Progyny, Inc. PGNY · Entity 4521 | SaleCommon Stock | 3,134 | $63.05 | $197,583.34 |
DisclosureSEC source: 0001179110-21-009865 · edgar.xml · nonDerivative · entry 4 Schlanger David J · CIK 0001576145 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan entered into on June 25, 2021. F3 · price: The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8).The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5), (6), (7) and (8). F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.17 inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.